Discussion | TAVI Session IV – Avoiding Pitfalls

preview_player
Показать описание
4/5Αίθουσα Banquet Hall, MAICC -
11:00-13:00 TAVI Session IV – Avoiding Pitfalls
Πρόεδροι: D. Alexopoulos,I. Ikonomidis,A. Manginas,A. Pipilis
11:00-11:15 A growing conundrum: Coronary access after TAVR. Difficulties, tips and tricks
V. Voudris
11:15-11:30 Mechanisms of coronary obstruction during and after TAVR: prediction, prevention, and treatment
N. Van Mieghem
11:30-11:45 Hybrid beating heart bypass grafting and TAVR. An excellent alternative?
N. Bouboulis
11:45-12:00 Guidelines and classification of bioprothetic TAVR and SAVR dysfunction and failure. Latest data on incidence, clinical impact and valve durability
A. Manginas
12:00-12:15 TAVR plus/minus AFib and/or CAD. Pharmacotherapy considerations, clinical trials and practical clinical recommendations
R. Mehran
12:15-12:30 The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies
G. Dangas
12:30-12:45 Live-in-a-box TAVR
12:45-13:00 Discussion
Σχολιαστές: N. Kadoglou,A. Roubelakis,G. Tsigas
  1. Livemedia
Рекомендации по теме
Discussion | TAVI 0:14:57

Discussion | TAVI Session IV – Avoiding Pitfalls

G. Pattakos | 0:11:51

G. Pattakos | Live in a Box | TAVI Session IV – Avoiding Pitfalls

TAVI Round Table 0:17:43

TAVI Round Table - Session 4: TAVI and Coronary Artery Disease

Discussion | TAVR 0:06:21

Discussion | TAVR Session V – Dealing with a “gray area”. Crucial questions and answers

Double jeopardy: coronary 0:54:59

Double jeopardy: coronary disease in patients undergoing TAVI - EuroPCR 2022

TAVI Round Table 0:25:40

TAVI Round Table - Session 2: Planning the Procedure

Impact of procedural 0:59:24

Impact of procedural outcomes on future TAVI treatment options - Webinar

TAVI Round Table 0:15:40

TAVI Round Table - Session 5: TAVI Complications

Maintaining selective coronary 0:44:53

Maintaining selective coronary access after TAVI and re-do TAVI procedures - PCR London Valves 2022

J. Velianou | 0:29:41

J. Velianou | 4. TAVI in complex scenarios

K. Toutouzas | 0:21:41

K. Toutouzas | 1. TAVI durability and long-term outcomes

[TCTAP & AP 1:12:52

[TCTAP & AP VALVES 2020] Highlight Session 4 Valve & Special Session IV TAVR Ongoing Issues

TAVI for AR 0:40:32

TAVI for AR - Addressing an unmet need with the JenaValve Trilogy heart valve system - EuroPCR 2022

TAVI Round Table 0:19:03

TAVI Round Table - Session 3: Aortic Regurgitation After TAVI

Redo-TAVI and patient 1:30:14

Redo-TAVI and patient pathway optimisation - EuroPCR 2023

Transcatheter Mitral Valve 0:31:30

Transcatheter Mitral Valve Implantation (TMVI) Round Table - Session 3 - Redo & De Novo Implanta...

TAVI Round Table 0:10:04

TAVI Round Table - Session 6: What's in the Pipeline?

Treating Bicuspid TAVI 0:12:13

Treating Bicuspid TAVI patients – Practical challenges and solutions - PCR Valves e-Course 2020

Planning for a 0:59:49

Planning for a long run: life-time management of bioprosthetic valve implantation - EuroPCR 2021

Disruptive Innovation: TAVR 0:47:04

Disruptive Innovation: TAVR 20 Years Later | April 4

TAVI outcomes in 0:15:49

TAVI outcomes in women with small annuli - EuroPCR 2021

V. Voudris | 0:15:09

V. Voudris | 4. TAVI in bicuspid anatomy

EuroPCR 2016 Great 0:00:54

EuroPCR 2016 Great Debate - extending TAVI to low risk patients: Lars Sondergaard

TAVI Round Table 0:27:56

TAVI Round Table - Session 1: Interpreting TAVI Research Data